Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from MedPal AI Plc ( (GB:MPAL) ).
MedPal AI has acquired key assets from Universal Pharmacy Limited, including a UK Distance Selling Pharmacy licence, for £45,000. This acquisition, conditional on NHS England’s approval, will enable MedPal AI to offer regulated online pharmaceutical services. Additionally, the company appointed Mike Rudin as Director of Online Pharmacy to enhance its operations. The acquisition positions MedPal AI strategically in the growing GLP-1 agonist market for obesity treatment, representing a significant revenue opportunity.
More about MedPal AI Plc
MedPal AI is a UK-based digital health company specializing in AI-driven wellness management. The company’s core app aggregates data from over 100 wearables and health apps into a unified profile, offering non-clinical, personalized lifestyle guidance through its AI wellness coach. MedPal AI is expanding its reach through partnerships and B2B licensing to healthcare providers, businesses, and insurers.
Average Trading Volume: 1,971,501
Find detailed analytics on MPAL stock on TipRanks’ Stock Analysis page.